Open AccessThe Montreal Cognitive Assessment Test
Author(s) -
Nicolas Paez-Venegas,
Bethel Jordan-Estrada,
Efraín Chavarría-Ávila,
Felipe Pérez-Vázquez,
Eduardo Gómez-Bañuelos,
Rafael Medina-Dávalos,
José-Ángel Ontiveros-González,
G. Diaz-Rubio,
Rosa Elevarro-Hernández,
Mónica Vázquez-Del Mercado
Publication year - 2018
Publication title -
journal of clinical rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.615
H-Index - 50
eISSN - 1536-7355
pISSN - 1076-1608
DOI - 10.1097/rhu.0000000000000876
Subject(s) - montreal cognitive assessment , medicine , gold standard (test) , cognition , cognitive impairment , neuropsychology , effects of sleep deprivation on cognitive performance , neuropsychological test , physical therapy , psychiatry
Systemic lupus erythematosus (SLE) is an inflammatory, chronic, and multisystemic disease, which may be associated with a wide range of neuropsychiatric manifestations, including cognitive impairment. Cognitive evaluations based on screening tests might identify early SLE-related cognitive alterations. The aim of this study was to evaluate and to compare the efficacy of three screening tests (Montreal Cognitive Assessment [MoCA], Mini Mental State Examination [MMSE], Cognitive Symptom Inventory [CSI]) against the gold standard (neuropsychological battery), in order to identify the most efficient screening test for cognitive impairment in patients with SLE.